27 related articles for article (PubMed ID: 38570540)
1. Novel nano-vehicle for delivery and efficiency of anticancer auraptene against colon cancer cells.
Jalilzadeh N; Samadi N; Salehi R; Dehghan G; Iranshahi M; Dadpour MR; Hamishehkar H
Sci Rep; 2020 Jan; 10(1):1606. PubMed ID: 32005894
[TBL] [Abstract][Full Text] [Related]
2. Synergy between Auraptene, Ionizing Radiation, and Anticancer Drugs in Colon Adenocarcinoma Cells.
Moussavi M; Haddad F; Rassouli FB; Iranshahi M; Soleymanifard S
Phytother Res; 2017 Sep; 31(9):1369-1375. PubMed ID: 28675489
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of hyperthermia in human colon adenocarcinoma cells is improved by auraptene.
Moussavi M; Haddad F; Matin MM; Iranshahi M; Rassouli FB
Biochem Cell Biol; 2018 Feb; 96(1):32-37. PubMed ID: 28915362
[TBL] [Abstract][Full Text] [Related]
4. Citrus auraptene exerts dose-dependent chemopreventive activity in rat large bowel tumorigenesis: the inhibition correlates with suppression of cell proliferation and lipid peroxidation and with induction of phase II drug-metabolizing enzymes.
Tanaka T; Kawabata K; Kakumoto M; Hara A; Murakami A; Kuki W; Takahashi Y; Yonei H; Maeda M; Ota T; Odashima S; Yamane T; Koshimizu K; Ohigashi H
Cancer Res; 1998 Jun; 58(12):2550-6. PubMed ID: 9635577
[TBL] [Abstract][Full Text] [Related]
5. Author Correction: Novel nano-vehicle for delivery and efficiency of anticancer auraptene against colon cancer cells.
Jalilzadeh N; Samadi N; Salehi R; Dehghan G; Iranshahi M; Dadpour MR; Hamishehkar H
Sci Rep; 2024 Apr; 14(1):7873. PubMed ID: 38570540
[No Abstract] [Full Text] [Related]
6. A Review of Auraptene as an Anticancer Agent.
Tayarani-Najaran Z; Tayarani-Najaran N; Eghbali S
Front Pharmacol; 2021; 12():698352. PubMed ID: 34239445
[TBL] [Abstract][Full Text] [Related]
7. Carbohydrate polymers-based surface modified nano delivery systems for enhanced target delivery to colon cancer - A review.
Ibrahim IAA; Alzahrani AR; Alanazi IM; Shahzad N; Shahid I; Falemban AH; Azlina MFN; Arulselvan P
Int J Biol Macromol; 2023 Dec; 253(Pt 2):126581. PubMed ID: 37652322
[TBL] [Abstract][Full Text] [Related]
8. Anticancer Activities of Surfactin and Potential Application of Nanotechnology Assisted Surfactin Delivery.
Wu YS; Ngai SC; Goh BH; Chan KG; Lee LH; Chuah LH
Front Pharmacol; 2017; 8():761. PubMed ID: 29123482
[TBL] [Abstract][Full Text] [Related]
9. A review of the pharmacological and therapeutic effects of auraptene.
Bibak B; Shakeri F; Barreto GE; Keshavarzi Z; Sathyapalan T; Sahebkar A
Biofactors; 2019 Nov; 45(6):867-879. PubMed ID: 31424600
[TBL] [Abstract][Full Text] [Related]
10. Auraptene and Its Role in Chronic Diseases.
Derosa G; Maffioli P; Sahebkar A
Adv Exp Med Biol; 2016; 929():399-407. PubMed ID: 27771936
[TBL] [Abstract][Full Text] [Related]
11. Effective Cancer Management: Inimitable Role of Phytochemical Based Nano- Formulations.
Upaganlawar A; Polshettiwar S; Raut S; Tagalpallewar A; Pande V
Curr Drug Metab; 2022; 23(11):869-881. PubMed ID: 36065928
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
